Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

Johann

Gudjonsson

,

MD, PhD

Professor of Dermatology
Professor of Internal Medicine, Division of Rheumatology
Director, University of Michigan Skin Research Center
University of Michigan, Department of Dermatology
Ann Arbor
,
Michigan
,
United States
Councilor Since: January 1, 2014
IPC Board Member
Dr. Johann Gudjonsson is the Arthur C. Curtis Professor of Skin Molecular Immunology and Professor of Dermatology, Internal Medicine Division of Rheumatology, and a Taubman Medical Research Institute Scholar at the University of Michigan. Dr. Gudjonsson is the Director of the Skin Research Center at the University of Michigan, and his primary research focus is basic immunological and genetic research on chronic inflammatory skin diseases. He has published over 390 peer-reviewed papers in top-tier journals, including Nature Immunology, Nature Genetics, Immunity, Journal of Clinical Investigation (JCI), and Science Translational Medicine. He received the Young Investigator Award from the American Academy of Dermatology (AAD) in 2007, and his work has earned several research awards, including those from the American Skin Association and the Doris Duke Foundation. He was selected as the Society for Investigative Dermatology (SID) Rising Star Lecturer in 2018. He was elected as a member of the American Society for Clinical Investigation (ASCI) in 2020 and the American Association of Physicians (AAP) in 2024 and is a Fellow of the American Association for the Advancement of Science (FAAAS). He has received several NIH R01, UO1, and P awards. He is the Director of the University of Michigan Skin Research Center, an NIH-sponsored P30 Research Core. He is on the Society for Investigative Dermatology Board of Directors, a Scientific Counselor to the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), and a member of the Board of Directors of the International Psoriasis Foundation (NPF).
Last Updated:
02/19/2026

Areas of Interest

Genetics, Genomics, Immunology of Psoriasis and Other Inflammatory Skin Disorders, Basic and Translational Research, Clinical Trials

IPC Committees / Groups

Board Member, Governance Committee, Research Committee, Symposia Committee

Languages Spoken

English, Icelandic

Involvement with Other Organization(s)

Dr. Gudjonsson serves on the Scientific Advisory and Medical Board of the National Psoriasis Foundation (NPF).

What's New

Global and Collaborative Research in Psoriasis: IPC Fellows Research Class #1 Recordings

Recordings from the IPC Fellows Research Class #1: Global and Collaborative Research in Psoriasis are now available. Program Chairs Peter van de Kerkhof, MD, PhD, and María Julia Cura, MD, led a faculty of international experts through sessions on unresolved questions in the era of effective psoriasis therapies, building global research collaborations, and connecting psoriasis research across disciplines. Watch to hear from Wolf Henning Boehncke, MD, MA, Christopher Griffiths, OBE, MD, FMedSci, and Georg Stingl, MD, as they share perspectives shaping the next generation of psoriasis research.

WATCH NOW

Wednesday, July 15, 2026

New in the IPC Resource Library: Research Skills

The IPC Resource Library now includes a dedicated Research Skills category, bringing together videos, articles, and presentations focused on building stronger research capabilities in psoriasis. Browse the current collection to find resources on topics from collaborative research methods to career development for researchers at every stage.

WATCH NOW

Thursday, July 13, 2026

New Take Tens on Psoriatic Arthritis

IPC Councilor Anna Lopez Ferrer, MD, PhD, reviews PURE-4, a four-item tool that helps dermatologists screen psoriasis patients for psoriatic arthritis (PsA) risk. She traces its evolution across three studies (2018–2026) into a validated predictor of early PsA.

IPC Councilor André Lucas Ribeiro, MD, reframes PsA as a slow transition from psoriasis, not a sudden event, opening the door to disease interception. He outlines the steps needed to get there, from harmonizing definitions to reducing inflammatory burden.

WATCH NOW

Wednesday, July 8, 2026